Published in Gene Therapy Weekly, April 21st, 1997
This is the first time that cryopreserved cord blood has been genetically modified and used in a clinical setting.
Shimon Slavin, Arnon Nagler, and Elizabeth Naparstek from the Hadassah Medical Center, Jerusalem, Israel, and Claudio Bordignon and Alessandro Aiuti, from the HS Raffaele Scientific Institute, Milan, Italy, collaborated on the procedure. As reported by Rachelle H.B. Fishman in The Lancet ("Frozen Cord Blood Used for Human Gene Therapy," March 8,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.